Meanwhile, there are no studies determining IDH1/2 mutations in clear cell ovarian carcinomas, which have a poorer prognosis than serous ovarian adenocarcinomas [22]. The gene discussed is IDH1; the disease is ovarian serous adenocarcinoma.